rtki cpd has been researched along with Subarachnoid Hemorrhage in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanamaru, H; Kawakita, F; Liu, L; Nakano, F; Nakatsuka, Y; Nishikawa, H; Okada, T; Suzuki, H | 1 |
| Kanamaru, H; Kawakita, F; Liu, L; Nakano, F; Nakatsuka, Y; Nishikawa, H; Okada, T; Pak, S; Shiba, M; Suzuki, H | 1 |
2 other study(ies) available for rtki cpd and Subarachnoid Hemorrhage
| Article | Year |
|---|---|
Epidermal Growth Factor Receptor Mediates Neuronal Apoptosis After Subarachnoid Hemorrhage in Mice.
Topics: Animals; Apoptosis; Caspase 3; Epidermal Growth Factor; ErbB Receptors; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; NF-kappa B; Subarachnoid Hemorrhage | 2023 |
Anti-vasospastic Effects of Epidermal Growth Factor Receptor Inhibitors After Subarachnoid Hemorrhage in Mice.
Topics: Animals; Cetuximab; ErbB Receptors; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Subarachnoid Hemorrhage; Tyrphostins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vasospasm, Intracranial | 2019 |